The estimated Net Worth of Janet Dillione is at least $2.76 Million dollars as of 14 August 2019. Ms. Dillione owns over 6,147 units of CorMedix Inc stock worth over $369,498 and over the last 14 years she sold CRMD stock worth over $2,230,319. In addition, she makes $160,800 as Independent Director at CorMedix Inc.
Sign up
Ms. Dillione CRMD stock SEC Form 4 insiders trading
Janet has made over 13 trades of the CorMedix Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently she bought 6,147 units of CRMD stock worth $50,344 on 14 August 2019.
The largest trade she's ever made was selling 63,430 units of CorMedix Inc stock on 9 August 2013 worth over $1,215,319. On average, Janet trades about 4,514 units every 43 days since 2010. As of 14 August 2019 she still owns at least 53,473 units of CorMedix Inc stock.
You can see the complete history of Ms. Dillione stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Janet Dillione biography
Janet M. Dillione is an Independent Director of CorMedix Inc. From May 2014 until May 2019, Ms. Dillione served as the Chief Executive Officer of Bernoulli Enterprise (formerly known as Cardiopulmonary Corp.), a leader in medical device connectivity for EMR integration, and integrated clinical applications and workflows for over 25 years. Previously, she was at Nuance Communications, Inc., a leading provider of voice and language solutions for businesses and consumers around the world, having joined Nuance in April 2010 as Executive Vice President and General Manager of the Healthcare Division and serving as an executive officer from March 2010 until May 2014. From June 2000 to March 2010, Ms. Dillione held several senior level management positions at Siemens Medical Solutions, a global leader in medical imaging, laboratory diagnostics, and healthcare information technology, including President and CEO of the global healthcare IT division. Ms. Dillione received her B.A. from Brown University in 1981 and completed the Executive Program at The Wharton School of Business of the University of Pennsylvania in 1998. She has over 25 years of experience leading global teams in the development and delivery of healthcare technology and services. She is a member of the board of CortiCare, a private U.S. based company. Among other qualifications, attributes and skills, Ms. Dillione’s financial expertise and significant executive management experience with medical device and healthcare companies led to the conclusion of our Board that she should serve as a director of our Company in light of our business and structure.
What is the salary of Janet Dillione?
As the Independent Director of CorMedix Inc, the total compensation of Janet Dillione at CorMedix Inc is $160,800. There are 11 executives at CorMedix Inc getting paid more, with Khoso Baluch having the highest compensation of $1,795,830.
How old is Janet Dillione?
Janet Dillione is 60, she's been the Independent Director of CorMedix Inc since 2015. There are 10 older and 3 younger executives at CorMedix Inc. The oldest executive at CorMedix Inc is John L. Armstrong Jr., 76, who is the Exec. VP for Technical Operations.
What's Janet Dillione's mailing address?
Janet's mailing address filed with the SEC is C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS, NJ, 07922.
Insiders trading at CorMedix Inc
Over the last 14 years, insiders at CorMedix Inc have traded over $693,980 worth of CorMedix Inc stock and bought 2,651,866 units worth $3,532,566 . The most active insiders traders include Mehmood Khan, Gary A. Gelbfish, and Brian Lenz. On average, CorMedix Inc executives and independent directors trade stock every 30 days with the average trade being worth of $199,105. The most recent stock trade was executed by Joseph Todisco on 13 March 2024, trading 13,561 units of CRMD stock currently worth $50,718.
What does CorMedix Inc do?
cormedix inc. is a company based out of 745 route 202-206, suite 303, bridgewater, nj, united states.
What does CorMedix Inc's logo look like?
Complete history of Ms. Dillione stock trades at Nuance Communications Inc and CorMedix Inc
CorMedix Inc executives and stock owners
CorMedix Inc executives and other stock owners filed with the SEC include:
-
Khoso Baluch,
Chief Executive Officer, Interim Principal Accounting Officer, Director -
Phoebe Mounts,
Executive Vice President, General Counsel, Head of Regulatory, Compliance and Legal -
Elizabeth Masson,
Executive Vice President - Head of Clinical Operations -
Khoso Baluch,
CEO & Director -
Dr. Phoebe Mounts Esq.,
Exec. VP, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal -
John Armstrong,
Executive Vice President - Technical Operations -
Elizabeth Masson-Hurlburt,
Exec. VP & Head of Clinical Operations -
John L. Armstrong Jr.,
Exec. VP for Technical Operations -
Alan Dunton,
Independent Director -
Myron Kaplan,
Independent Chairman of the Board -
Steven Lefkowitz,
Independent Director -
Janet Dillione,
Independent Director -
Gregory Duncan,
Director -
Paulo Costa,
Director -
Matthew David,
Chief Financial Officer, Executive Vice President -
Thomas Nusbickel,
Exec. VP & Chief Commercial Officer -
Dr. Paul Chew M.D.,
Acting Chief Medical Officer -
Dr. Paul Chew,
Acting Chief Medical Officer -
Dr. Matthew T. David M.D.,
Exec. VP & CFO -
Judith R Abrams,
Chief Medical Officer -
Robert W. Cook,
Chief Financial Officer -
Taunia Markvicka,
Director -
Antony Pfaffle,
Director -
Randy Milby,
Chief Operating Officer -
Cora M Tellez,
Director -
Mehmood Khan,
-
Michael W George,
Director -
Gary A. Gelbfish,
Director -
James Lefkowitz,
Director -
Bami Bastani,
Director -
Timothy M Hofer,
Secretary -
Mark T. Houser,
Chief Medical Officer -
John C. Houghton,
President and CEO -
Mark A. Klausner,
Chief Medical Officer -
Russell H Ellison,
Director -
Robert A Stewart,
-
Matthew Duffy,
Director -
Harry O'grady,
Chief Financial Officer -
Richard Cohen,
Director -
Development Inc Pharmabio,
10% owner -
Brian Lenz,
Chief Financial Officer -
Thomas Nusbickel,
EVP, Chief Commercial Officer -
Joseph Todisco,
Chief Executive Officer -
Kaufman Beth Zelnick,
Chief Legal Officer -
Erin Mistry,
Chief Commercial Officer